Key result
Circulating microparticles from Trypanosoma cruzi infection reflect the in vivo oxidative and inflammatory state, inducing macrophage activation and disease-state-specific gene expression.
Circulating microparticles in Chagas disease reflect the in vivo oxidative and inflammatory state and may serve as biomarkers for disease severity and therapeutic efficacy in chagasic cardiomyopathy.
MPs may track CCM severity and therapy response; leaves open biomarker validation before clinical adoption.
BACKGROUND: Chronic inflammation and oxidative stress are hallmarks of chagasic cardiomyopathy (CCM). In this study, we determined if microparticles (MPs) generated during Trypanosoma cruzi (Tc) infection carry the host's signature of the inflammatory/oxidative state and provide information regarding the progression of clinical disease. METHODS: MPs were harvested from supernatants of human peripheral blood mononuclear cells in vitro incubated with Tc (control: LPS treated), plasma of seropositive humans with a clinically asymptomatic (CA) or symptomatic (CS) disease state (vs. normal/healthy [NH] controls), and plasma of mice immunized with a protective vaccine before challenge infection (control: unvaccinated/infected). Macrophages (mφs) were incubated with MPs, and we probed the gene expression profile using the inflammatory signaling cascade and cytokine/chemokine arrays, phenotypic markers of mφ activation by flow cytometry, cytokine profile by means of an ELISA and Bioplex assay, and oxidative/nitrosative stress and mitotoxicity by means of colorimetric and fluorometric assays. RESULTS: Tc- and LPS-induced MPs stimulated proliferation, inflammatory gene expression profile, and nitric oxide (∙NO) release in human THP-1 mφs. LPS-MPs were more immunostimulatory than Tc-MPs. Endothelial cells, T lymphocytes, and mφs were the major source of MPs shed in the plasma of chagasic humans and experimentally infected mice. The CS and CA (vs. NH) MPs elicited >2-fold increase in NO and mitochondrial oxidative stress in THP-1 mφs; however, CS (vs. CA) MPs elicited a more pronounced and disease-state-specific inflammatory gene expression profile (IKBKB, NR3C1, and TIRAP vs. CCR4, EGR2, and CCL3), cytokine release (IL-2 + IFN-γ > GCSF), and surface markers of mφ activation (CD14 and CD16). The circulatory MPs of nonvaccinated/infected mice induced 7.5-fold and 40% increases in ∙NO and IFN-γ production, respectively, while these responses were abolished when RAW264.7 mφs were incubated with circulatory MPs of vaccinated/infected mice. CONCLUSION: Circulating MPs reflect in vivo levels of an oxidative, nitrosative, and inflammatory state, and have potential utility in evaluating disease severity and the efficacy of vaccines and drug therapies against CCM.
No takes yet. Share an insight, caveat, or question.
Chowdhury et al. (2016) studied Trypanosoma cruzi infection and Chagas disease. Microparticles from Trypanosoma cruzi infection vs. Microparticles from normal/healthy controls or LPS treatment was evaluated on Macrophage inflammatory gene expression, cytokine release, and oxidative stress. Circulating microparticles from Trypanosoma cruzi infection reflect the in vivo oxidative and inflammatory state, inducing macrophage activation and disease-state-specific gene expression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: